| ■ 영문 제목 : Global Hemophillia A and B Therapeutics Materials Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00221 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 80 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (데스모프레신, 옥토코갈파, 노나코갈파, 기타)와 용도별 시장규모 (병원, 외래 외과 센터) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 혈우병 A 및 B 치료제 시장 점유율 - 지역별 혈우병 A 및 B 치료제 시장규모 - 주요지역의 종류별 시장규모 (데스모프레신, 옥토코갈파, 노나코갈파, 기타) - 주요지역의 용도별 시장규모 (병원, 외래 외과 센터) - 미주의 혈우병 A 및 B 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 혈우병 A 및 B 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 혈우병 A 및 B 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 혈우병 A 및 B 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 혈우병 A 및 B 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Arsia therapeutics, Spark Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Sangamo Therapeutics, Inc. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hemophillia A and B Therapeutics Materials market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemophillia A and B Therapeutics Materials market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Desmopressin
Octocogalfa
Nonacogalfa
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Ambulatory Surgical Centers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Arsia therapeutics
Spark Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Sangamo Therapeutics, Inc.
1 Scope of the Report 2 Executive Summary 3 Hemophillia A and B Therapeutics Materials Market Size by Players 4 Hemophillia A and B Therapeutics Materials by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Hemophillia A and B Therapeutics Materials Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Hemophillia A and B Therapeutics Materials Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Desmopressin Table 3. Major Players of Octocogalfa Table 4. Major Players of Nonacogalfa Table 5. Major Players of Others Table 6. Hemophillia A and B Therapeutics Materials Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Type (2016-2021) Table 9. Hemophillia A and B Therapeutics Materials Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Application (2016-2021) Table 12. Global Hemophillia A and B Therapeutics Materials Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Players (2019-2021E) Table 14. Hemophillia A and B Therapeutics Materials Key Players Head office and Products Offered Table 15. Hemophillia A and B Therapeutics Materials Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Hemophillia A and B Therapeutics Materials Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Regions 2016-2021 Table 20. Americas Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Country (2016-2021) Table 22. Americas Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Type (2016-2021) Table 24. Americas Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Application (2016-2021) Table 26. APAC Hemophillia A and B Therapeutics Materials Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Region (2016-2021) Table 28. APAC Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Type (2016-2021) Table 30. APAC Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Application (2016-2021) Table 32. Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Country (2016-2021) Table 34. Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Type (2016-2021) Table 36. Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Hemophillia A and B Therapeutics Materials Table 45. Key Application and Potential Industries of Hemophillia A and B Therapeutics Materials Table 46. Key Challenges of Hemophillia A and B Therapeutics Materials Table 47. Key Trends of Hemophillia A and B Therapeutics Materials Table 48. Global Hemophillia A and B Therapeutics Materials Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Hemophillia A and B Therapeutics Materials Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Hemophillia A and B Therapeutics Materials Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Hemophillia A and B Therapeutics Materials Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Hemophillia A and B Therapeutics Materials Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Hemophillia A and B Therapeutics Materials Market Size Market Share Forecast by Application (2021-2026) Table 54. Arsia therapeutics Details, Company Type, Hemophillia A and B Therapeutics Materials Area Served and Its Competitors Table 55. Arsia therapeutics Hemophillia A and B Therapeutics Materials Product Offered Table 56. Arsia therapeutics Hemophillia A and B Therapeutics Materials Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Arsia therapeutics Main Business Table 58. Arsia therapeutics Latest Developments Table 59. Spark Therapeutics, Inc. Details, Company Type, Hemophillia A and B Therapeutics Materials Area Served and Its Competitors Table 60. Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Offered Table 61. Spark Therapeutics, Inc. Main Business Table 62. Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Spark Therapeutics, Inc. Latest Developments Table 64. Alnylam Pharmaceuticals, Inc. Details, Company Type, Hemophillia A and B Therapeutics Materials Area Served and Its Competitors Table 65. Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Product Offered Table 66. Alnylam Pharmaceuticals, Inc. Main Business Table 67. Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Alnylam Pharmaceuticals, Inc. Latest Developments Table 69. Sangamo Therapeutics, Inc. Details, Company Type, Hemophillia A and B Therapeutics Materials Area Served and Its Competitors Table 70. Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Offered Table 71. Sangamo Therapeutics, Inc. Main Business Table 72. Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Sangamo Therapeutics, Inc. Latest Developments List of Figures Figure 1. Hemophillia A and B Therapeutics Materials Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Type in 2020 Figure 7. Hemophillia A and B Therapeutics Materials in Hospitals Figure 8. Global Hemophillia A and B Therapeutics Materials Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Hemophillia A and B Therapeutics Materials in Ambulatory Surgical Centers Figure 10. Global Hemophillia A and B Therapeutics Materials Market: Ambulatory Surgical Centers (2016-2021) & ($ Millions) Figure 11. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Application in 2020 Figure 12. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Player in 2020 Figure 13. Global Hemophillia A and B Therapeutics Materials Market Size Market Share by Regions (2016-2021) Figure 14. Americas Hemophillia A and B Therapeutics Materials Market Size 2016-2021 ($ Millions) Figure 15. APAC Hemophillia A and B Therapeutics Materials Market Size 2016-2021 ($ Millions) Figure 16. Europe Hemophillia A and B Therapeutics Materials Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size 2016-2021 ($ Millions) Figure 18. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Country in 2020 Figure 19. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Type in 2020 Figure 20. Americas Hemophillia A and B Therapeutics Materials Market Size Market Share by Application in 2020 Figure 21. United States Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Regions in 2020 Figure 25. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Type in 2020 Figure 26. APAC Hemophillia A and B Therapeutics Materials Market Size Market Share by Application in 2020 Figure 27. China Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 31. India Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Country in 2020 Figure 34. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Type in 2020 Figure 35. Europe Hemophillia A and B Therapeutics Materials Market Size Market Share by Application in 2020 Figure 36. Germany Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 37. France Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size Market Share by Application in 2020 Figure 44. Egypt Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Hemophillia A and B Therapeutics Materials Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 50. APAC Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 51. Europe Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 53. United States Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 54. Canada Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 55. Mexico Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 56. Brazil Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 57. China Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 58. Japan Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 59. Korea Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 61. India Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 62. Australia Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 63. Germany Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 64. France Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 65. UK Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 66. Italy Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 67. Russia Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 68. Spain Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 69. Egypt Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 70. South Africa Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 71. Israel Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 72. Turkey Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Hemophillia A and B Therapeutics Materials Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K00221) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |